Overview

A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Status:
NOT_YET_RECRUITING
Trial end date:
2026-04-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of KarXT administration on the drug levels of midazolam, fexofenadine, and digoxin in healthy adult participants.
Phase:
PHASE1
Details
Lead Sponsor:
Karuna Therapeutics
Treatments:
Digoxin
fexofenadine
Midazolam
trospium chloride
xanomeline